Prostate-specific antigen (PSA) values in patients with low- and high-risk prostatic adenocarcinoma (CROSBI ID 287231)
Prilog u časopisu | izvorni znanstveni rad | domaća recenzija
Podaci o odgovornosti
Mašić, Silvija ; Pezelj, Ivan ; Krušlin, Božo
engleski
Prostate-specific antigen (PSA) values in patients with low- and high-risk prostatic adenocarcinoma
Prostatic adenocarcinoma (PC) comprises around 19% of malignancies in Croatian male population. On the basis of PSA value, Gleason score, grading group and clinical stage, PC can be classified into low- and high-risk groups which is significant for different therapeutic regimens and prognostic outcomes. In this retrospective study, we analyzed the difference in preoperative PSA value in a group of 272 patients who underwent radical prostatectomy and were diagnosed with PC adenocarcinoma in our institution in a period from January 1st, 2018 untill December 31st, 2018. Subsequently, they were divided into low- and high-risk prostatic adenocarcinoma groups. Our results demonstrated positive correlation in preoperative PSA values between the groups and therefore support the use
prostatic adenocarcinoma ; psa ; gleason grade ; low-risk ; high-risk
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
58 (Suppl. 2)
2019.
12-16
objavljeno
0353-9466
1333-9451
10.20471/acc.2019.58.s2.02
Povezanost rada
Kliničke medicinske znanosti